Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
UCB is seeking a motivated, detail-oriented Business Analyst Trainee to join the UK & Ireland team. This entry-level role builds a career in commercial business analysis, focusing on data interpretation and analytics. You will back the team with insights, reports, and data-driven decisions.
The role requires a Bachelor’s degree in a related field and offers a 1-year duration with competitive benefits and structured onboarding to support growth.
UCB are seeking a motivated and detail oriented business analyst trainee to join their UK & Ireland team. This entry-level role is ideal for someone looking to build a career in commercial business analysis, with a strong foundation in data interpretation and analytics. You will support the business analyst team in gathering insights for the business stakeholders, preparing reports, and contributing to data-driven decision-making.
Qualification Requirements
You must have graduated with a Bachelor’s degree in business, Science, Economics, Statistics, Computer Science, or a related field
Salary - £28,000 per annum
Benefits
Location - 208 Bath Rd, Slough SL1 3WE until approximately April 2027 where UCB will move to a new site: UCB Sunninghill Road, Windlesham, Surrey, GU20 6PP
Working Hours
Monday to Friday 9:00am – 17:30pm with 1 hour unpaid lunch break.
Duration - 1 year
Start Date - 7th December 2026
Interview Date -Week commencing 16th November2026
Closing Date for Applications - Thursday 5th November 2026
As a Trainee, you support the Business Analyst of UK and Ireland. You enjoy working in a cross-functional environment where you can:
Your typical working day will involve:
Skills/Personal Qualities
UCB is a global biopharmaceutical company, with a focus on neurology and immunology.
UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the centre of our world. We are Inspired by Patients. Driven by Science and are now more than 9000 people in all four corners of the globe.
Our medicines treat millions of people around the world, and we are engaging with patients, their families and healthcare professionals to address their unmet needs. We want to enhance our understanding of disease and the real-life experiences of patients so that our teams can deliver the right drug and the right care to the right patient.
UCB is continuously working to advance science and embrace new knowledge. We are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. Patients inspire us to bring them value through cutting-edge science, innovative treatments, and practical solutions – so that they and their carers can get on with their lives